Researchers conducted this randomised, double-blind, placebo-controlled, phase 2 trial to test the safety and effectiveness of adjuvant nivolumab plus ipilimumab or nivolumab monotherapy vs a placebo in patients with stage IV melanoma with no evidence of disease.
Publications
Patterns of omega-3 and omega-6 fatty acid dietary intake and melanoma thickness at diagnosis
As per experimental evidence, dietary intakes of omega-3 and omega-6 polyunsaturated fatty acids (FAs) have divergent effects on melanoma growth, researchers here sought for epidemiologic evidence on their combined effect.
Melanoma Journal Articles for Feb-April 2020
Please click on the link to see a list of melanoma journal articles that came across the MRV desk recently.
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response
Given that objective responses in 30% to 50% of patients suffering from metastatic melanoma is mediated by adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TIL), as per multiple, small phase 2 trials, so, researchers assessed long-term clinical outcomes, intent-to-treat analysis, predictors of response as well as toxicity profile in a large patient cohort.